Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

This article is part of the supplement: Lupus 2012: New targets, new approaches

Meeting abstract

Serum α-chlorofatty acid as a biomarker for baseline subclinical cardiovascular disease in systemic lupus erythematosus

MA Mahieu, C Guild, CJ Albert, G Kondos, J Carr, D Edmundowicz, DA Ford and R Ramsey-Goldman*

  • * Corresponding author: R Ramsey-Goldman

  • † Equal contributors

Arthritis Research & Therapy 2012, 14(Suppl 3):A22  doi:10.1186/ar3956

Article Metrics

457
Total accesses

Article metric FAQ

Accesses  

  • Last 30 days: 14 accesses
  • Last 365 days: 163 accesses
  • All time: 457 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information